COLOMBATTI, Alfonso
 Distribuzione geografica
Continente #
NA - Nord America 2.820
EU - Europa 519
AS - Asia 141
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 1
OC - Oceania 1
Totale 3.486
Nazione #
US - Stati Uniti d'America 2.790
UA - Ucraina 220
CN - Cina 88
DE - Germania 83
FI - Finlandia 76
IT - Italia 45
IE - Irlanda 39
CA - Canada 30
SE - Svezia 20
IR - Iran 13
SG - Singapore 11
TR - Turchia 10
IN - India 8
GB - Regno Unito 7
CZ - Repubblica Ceca 5
KR - Corea 5
LI - Liechtenstein 5
EU - Europa 4
VN - Vietnam 4
BE - Belgio 3
RU - Federazione Russa 3
HR - Croazia 2
PL - Polonia 2
RS - Serbia 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
DK - Danimarca 1
EE - Estonia 1
FR - Francia 1
JP - Giappone 1
LK - Sri Lanka 1
NO - Norvegia 1
TG - Togo 1
Totale 3.486
Città #
Fairfield 435
Woodbridge 331
Ann Arbor 252
Houston 212
Chandler 188
Seattle 181
Ashburn 179
Cambridge 174
Jacksonville 147
Wilmington 141
Dearborn 95
Beijing 43
New York 43
Dublin 39
Princeton 39
Ottawa 27
Udine 22
San Diego 15
Norwalk 12
Hefei 11
Izmir 10
Singapore 10
Ogden 8
Des Moines 7
Boardman 6
Kunming 6
Fremont 5
Los Angeles 5
Nanjing 5
Schaan 5
Dong Ket 4
Wuhan 4
Augusta 3
Brno 3
Brussels 3
Helsinki 3
Pune 3
Zanjan 3
Ardabil 2
Belgrade 2
Centro 2
Edinburgh 2
Guangzhou 2
Hebei 2
Leawood 2
Milan 2
Nanchang 2
Phoenix 2
Prague 2
Stockholm 2
Warsaw 2
Washington 2
Zagreb 2
Adelaide 1
Andover 1
Baotou 1
Changchun 1
Changsha 1
Chaoyang 1
Charlotte 1
Chicago 1
Copenhagen 1
Dambulla 1
Easton 1
Frankfurt am Main 1
Grafing 1
Guiyang 1
Indiana 1
Islington 1
Jinan 1
Kashan 1
Kish 1
Lomé 1
London 1
Miami 1
Monmouth Junction 1
Montreal 1
New Delhi 1
New Orleans 1
Ningbo 1
Oslo 1
Paris 1
Redwood City 1
Reston 1
San Francisco 1
Schiavon 1
Shanghai 1
Sofia 1
Taiyuan 1
Tallinn 1
Tappahannock 1
Tirana 1
Tokyo 1
Toronto 1
Trieste 1
Venezia 1
Vienna 1
Winnipeg 1
Yeongdeungpo-gu 1
Zhengzhou 1
Totale 2.756
Nome #
BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress 146
Differential proteomic analysis of hepatocellular carcinoma 127
Emerging Technologies for Cancer Research: towards Personalized Medicine with Microfluidic Platforms and 3D Tumor Models 127
A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction 124
Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts 123
Long non-coding RNAs and cancer: a new frontier of translational research? 118
Identification of P-glycoprotein at the membrane of mast cell secretoty granules. 112
Signature of B-CLL with different prognosis by Shrunken centroids of surface antigen expression profiling. 110
Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding 101
p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion 100
Abrogation of EMILIN1-β1 integrin interaction promotes experimental colitis and colon carcinogenesis 100
The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transition 99
Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma. 99
Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer. 99
Regulation of the Extrinsic Apoptotic Pathway by the Extracellular Matrix Glycoprotein EMILIN2 95
The extracellular matrix glycoprotein elastin microfibril interface located protein 2: a dual role in the tumor microenvironment 95
Blood–derived human osteoclast resorption activity is impaired by hyaluronan-CD44 engagement via a p38-dependent mechanism 91
Expression profiles in malignant fibrous histiocytomas: clues for differentiating 'spindle cell' and 'pleomorphic' subtypes. 90
EMILINs interact with anthrax protective antigen and inhibit toxin action in vitro. 89
EMILIN1 represents a major stromal element determining human trophoblast invasion of the uterine wall 89
Identification of P-glycoprotein at the membrane of mast cell secretoty granules. 89
NMR-based homology model for the solution structure of the C-terminal globular domain of EMILIN1 89
The EMILIN/multimerin family 85
Emilin1 deficiency causes structural and functional defects of lymphatic vasculature 85
Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions. 85
MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway. 84
p27kip1 controls cell morphology and motility by regulating microtubule-dependent lipid raft recycling. 82
Mutational status of IgVH genes consistent with antigen-driven selection but not percent of mutations has prognostic impact in B-cell chronic lymphocytic leukemia. 76
Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing 74
p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis. 71
Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells. 71
EMILIN1-α4/α9 integrin interaction inhibits dermal fibroblast and keratinocyte proliferation. 70
Cooperative activity of alpha4beta1 and alpha4beta7 integrins in mediating human B-cell lymphoma adhesion and chemotaxis on fibronectin through recognition of multiple synergizing binding sites within the central cell-binding domain 69
Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer. 69
Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. 64
Bovine heart ATPsynthase dimerization: involvement of F0 anf F1 subunits 58
Surface-antigen expression profiling (SEP) in B-cell chronic linphocytic leukemia (B-CLL):Identification of markers with prognostic relevance. 56
Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery 51
The solution structure of EMILIN1 globular C1q domain reveals a disordered insertion necessary for interaction with the alpha4beta1 integrin 47
Totale 3.509
Categoria #
all - tutte 10.070
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.070


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.154 70 69 55 184 86 168 136 136 90 73 14 73
2020/2021544 25 67 17 71 29 71 34 56 64 22 63 25
2021/2022309 16 30 7 10 0 17 22 13 3 57 77 57
2022/2023406 40 25 13 69 30 108 0 36 51 2 26 6
2023/2024147 16 12 4 1 19 62 2 5 10 6 1 9
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 3.509